• Users Online: 243
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
Year : 2019  |  Volume : 5  |  Issue : 2  |  Page : 85-88

Shorter drug regimen of multidrug-resistant tuberculosis and the ambiguity in the World Health Organization recommendations

1 Department of Community Medicine, Government Medical College, Srinagar, Jammu and Kashmir, India
2 Directorate of Health Services, Srinagar, Jammu and Kashmir, India

Correspondence Address:
Rabbanie Tariq Wani
H# 39, Lane 3rd, Ibrahim Colony, Hyderpora, Srinagar, Jammu and Kashmir
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/jcrsm.jcrsm_12_19

Rights and Permissions

Organizations all over world are trying to shift towards making healthcare intervention more acceptable to the consumers at large, but any intervention made has its costeffective and costbeneficial implications which should be taken into consideration while incorporating changes. A recent change of switching to shorter regimen for multidrugresistant tuberculosis (MDRTB) can be a landmark step in the treatment of the disease but it has its own limitations which need to be addressed.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded303    
    Comments [Add]    

Recommend this journal